-
Something wrong with this record ?
Morphological Characterization of Papillary Renal Cell Carcinoma Type 1, the Efficiency of Its Surgical Treatment
K. Procházková, M. Staehler, I. Trávníček, T. Pitra, V. Eret, T. Ürge, L. Eberlová, M. Roušarová, P. Hošek, Z. Chudáček, J. Ferda, O. Hes, M. Hora,
Language English Country Switzerland
Document type Journal Article
PubMed
27684070
DOI
10.1159/000448434
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Carcinoma, Renal Cell surgery MeSH
- Kidney pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Survival Rate MeSH
- Kidney Neoplasms surgery MeSH
- Nephrectomy * MeSH
- Nephrons surgery MeSH
- Prognosis MeSH
- Proportional Hazards Models MeSH
- Retrospective Studies MeSH
- Chi-Square Distribution MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
AIM: Papillary renal cell carcinoma type 1 (pRCC1) represents the second most common type of malignant renal epithelial tumour. The origin of its characteristic appearance, its growth mechanism, and the long-term efficiency of its surgical treatment remain uncertain. Our aim was to determine typical characteristics of surgically treated pRCC1. METHODS: pRCC1 was verified in 83 of 1,629 (5.1%) kidney tumours surgically treated in the period of January 2007-January 2016. The clinical and radiological characteristics, type of surgery, histopathology results and follow up data were recorded. Spearman correlation, Kruskal-Wallis analysis of variance, Fisher's exact, and chi-square test were used to analyse appropriate variables. The overall survival rate was evaluated using the Gehan-Wilcoxon test and the Cox proportional hazards model. RESULTS: The mean tumour size was 52.0 mm (15-180); 98.8% of the tumours showed a spherical shape and in 82.1%, exophytic growth was observed. Partial nephrectomy was performed in 80.7%. A majority (81.9%) were classified as pT1. Tumours, 89.2% of them, belonged to Fuhrman grade 1 or 2. The mean follow-up was 46.8 months. The overall survival was associated with pT category (p ≤ 0.0001). CONCLUSIONS: Typical signs of pRCC1 are a spherical shape, exophytic growth and low Fuhrman's grade. More than three-fourths of pRCC1 could be treated by the nephron-sparing surgery.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017018
- 003
- CZ-PrNML
- 005
- 20180523133000.0
- 007
- ta
- 008
- 180515s2017 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000448434 $2 doi
- 035 __
- $a (PubMed)27684070
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Procházková, Kristýna $u Department of Urology, University Hospital Pilsen, Pilsen, Czech Republic.
- 245 10
- $a Morphological Characterization of Papillary Renal Cell Carcinoma Type 1, the Efficiency of Its Surgical Treatment / $c K. Procházková, M. Staehler, I. Trávníček, T. Pitra, V. Eret, T. Ürge, L. Eberlová, M. Roušarová, P. Hošek, Z. Chudáček, J. Ferda, O. Hes, M. Hora,
- 520 9_
- $a AIM: Papillary renal cell carcinoma type 1 (pRCC1) represents the second most common type of malignant renal epithelial tumour. The origin of its characteristic appearance, its growth mechanism, and the long-term efficiency of its surgical treatment remain uncertain. Our aim was to determine typical characteristics of surgically treated pRCC1. METHODS: pRCC1 was verified in 83 of 1,629 (5.1%) kidney tumours surgically treated in the period of January 2007-January 2016. The clinical and radiological characteristics, type of surgery, histopathology results and follow up data were recorded. Spearman correlation, Kruskal-Wallis analysis of variance, Fisher's exact, and chi-square test were used to analyse appropriate variables. The overall survival rate was evaluated using the Gehan-Wilcoxon test and the Cox proportional hazards model. RESULTS: The mean tumour size was 52.0 mm (15-180); 98.8% of the tumours showed a spherical shape and in 82.1%, exophytic growth was observed. Partial nephrectomy was performed in 80.7%. A majority (81.9%) were classified as pT1. Tumours, 89.2% of them, belonged to Fuhrman grade 1 or 2. The mean follow-up was 46.8 months. The overall survival was associated with pT category (p ≤ 0.0001). CONCLUSIONS: Typical signs of pRCC1 are a spherical shape, exophytic growth and low Fuhrman's grade. More than three-fourths of pRCC1 could be treated by the nephron-sparing surgery.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a karcinom z renálních buněk $x chirurgie $7 D002292
- 650 _2
- $a rozdělení chí kvadrát $7 D016009
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ledviny $x patologie $7 D007668
- 650 _2
- $a nádory ledvin $x chirurgie $7 D007680
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a nefrektomie $7 D009392
- 650 _2
- $a nefrony $x chirurgie $7 D009399
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a proporcionální rizikové modely $7 D016016
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Staehler, Michael
- 700 1_
- $a Trávníček, Ivan
- 700 1_
- $a Pitra, Tomáš
- 700 1_
- $a Eret, Viktor
- 700 1_
- $a Ürge, Tomáš
- 700 1_
- $a Eberlová, Lada
- 700 1_
- $a Roušarová, Milena
- 700 1_
- $a Hošek, Petr $7 xx0224573
- 700 1_
- $a Chudáček, Zdeněk
- 700 1_
- $a Ferda, Jiří
- 700 1_
- $a Hes, Ondřej
- 700 1_
- $a Hora, Milan
- 773 0_
- $w MED00004616 $t Urologia internationalis $x 1423-0399 $g Roč. 98, č. 2 (2017), s. 148-155
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27684070 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180523133145 $b ABA008
- 999 __
- $a ok $b bmc $g 1300642 $s 1013858
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 98 $c 2 $d 148-155 $e 20160930 $i 1423-0399 $m Urologia internationalis $n Urol Int $x MED00004616
- LZP __
- $a Pubmed-20180515